跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMACOR SOLIFENACIN solifenacin succinate 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PHARMACOR SOLIFENACIN solifenacin succinate 5 mg tablet blister pack
Approved
STANDARD
PHARMACOR SOLIFENACIN solifenacin succinate 5 mg tablet blister pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d0282aefce517e37
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
d0282aefce517e37
Product Name
PHARMACOR SOLIFENACIN solifenacin succinate 5 mg tablet blister pack
Artg Id
288255
Artg Name
PHARMACOR SOLIFENACIN solifenacin succinate 5 mg tablet blister pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2018-04-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8fbe48ae94489dcca3cc586f0b6661f5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/aa2912b125c5b86cde3b0d03f90e85c3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d0282aefce517e37
Type
Standard
Back to TGA Approvals